The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples